BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
-5.34%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$319M
AUM Growth
+$319M
(-22%)
Cap. Flow
-$67.6M
Cap. Flow
% of AUM
-21.22%
Top 10 Holdings %
Top 10 Hldgs %
52.41%
Holding
49
New
12
Increased
7
Reduced
19
Closed
7
Top Buys
| 1 |
AMRN
Amarin Corp
AMRN
|
$19.4M |
| 2 |
XENT
Intersect ENT, Inc
XENT
|
$13.3M |
| 3 |
AbbVie
ABBV
|
$11.7M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
$10.2M |
| 5 |
PGNX
Progenics Pharmaceuticals Inc
PGNX
|
$8.01M |
Top Sells
| 1 |
PETX
Aratana Therapeutics, Inc.
PETX
|
$37.5M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
$29M |
| 3 |
Heron Therapeutics
HRTX
|
$10.4M |
| 4 |
Catalyst Pharmaceutical
CPRX
|
$10M |
| 5 |
DexCom
DXCM
|
$9.49M |
Sector Composition
| 1 | Healthcare | 91.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRN
1
Amarin Corp
AMRN
$311M
| $23.8M | 4.4% | 1,569,011 +1,278,011 | +439% | +$19.4M |
|
|
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $22.2M | 4.11% | 532,591 -144,288 | -21% | -$6.02M |
|
3
Iovance Biotherapeutics
IOVA
$807M
| $20.6M | 3.81% | 1,131,101 -428,198 | -27% | -$7.79M |
|
|
BDSI
4
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $18.1M | 3.35% | 4,300,066 +18,123 | +0.4% | +$76.3K |
|
|
AGN
5
DELISTED
Allergan plc
AGN
| $16.2M | 3% | 96,504 -18,300 | -16% | -$3.08M |
|
|
EIGR
6
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $14M | 2.59% | 1,367,377 -288,760 | -17% | -$2.96M |
|
|
XENT
7
DELISTED
Intersect ENT, Inc
XENT
| $13.3M | 2.45% | +779,134 | New | +$13.3M |
|
|
SIEN
8
DELISTED
Sientra, Inc.
SIEN
| $13M | 2.4% | 2,001,895 +601,895 | +43% | +$3.9M |
|
|
NVRO
9
DELISTED
NEVRO CORP.
NVRO
| $12.9M | 2.39% | 150,510 -337,755 | -69% | -$29M |
|
|
AVDL
10
Avadel Pharmaceuticals
AVDL
$1.43B
| $12.9M | 2.39% | 3,102,673 | – | – |
|
|
WMGI
11
DELISTED
Wright Medical Group Inc
WMGI
| $12.8M | 2.36% | 618,500 +492,100 | +389% | +$10.2M |
|
|
12
AbbVie
ABBV
$372B
| $11.7M | 2.16% | +154,500 | New | +$11.7M |
|
|
SCTL
13
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $10.9M | 2.02% | 987,760 -573,857 | -37% | -$6.36M |
|
|
VRAY
14
DELISTED
ViewRay, Inc.
VRAY
| $8.7M | 1.61% | 3,001,361 +2,134,861 | +246% | +$6.19M |
|
|
GBT
15
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $8.59M | 1.59% | 177,016 -139,603 | -44% | -$6.77M |
|
|
PGNX
16
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $8.01M | 1.48% | +1,583,925 | New | +$8.01M |
|
17
Travere Therapeutics
TVTX
$1.56B
| $7.08M | 1.31% | 610,414 -442,900 | -42% | -$5.13M |
|
18
Strata Skin Sciences
SSKN
$9.93M
| $6.27M | 1.16% | 2,916,915 -339,700 | -10% | -$730K |
|
|
SBBP
19
DELISTED
Strongbridge Biopharma plc.
SBBP
| $6.16M | 1.14% | 2,578,003 +33,164 | +1% | +$79.3K |
|
20
Exicure
XCUR
$35.4M
| $5.85M | 1.08% | +2,311,906 | New | +$5.85M |
|
|
ZGNX
21
DELISTED
Zogenix, Inc.
ZGNX
| $5.53M | 1.02% | 138,037 -206,725 | -60% | -$8.28M |
|
22
Sol-Gel Technologies
SLGL
$63.5M
| $5.06M | 0.94% | 563,300 -166,800 | -23% | -$1.5M |
|
23
Alkermes
ALKS
$4.78B
| $4.86M | 0.9% | +249,000 | New | +$4.86M |
|
24
Exagen
XGN
$217M
| $4.82M | 0.89% | +311,284 | New | +$4.82M |
|
25
ICU Medical
ICUI
$3.15B
| $4.79M | 0.89% | +30,000 | New | +$4.79M |
|